These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Safety and immunogenicity of a nicotine conjugate vaccine in current smokers. Hatsukami DK; Rennard S; Jorenby D; Fiore M; Koopmeiners J; de Vos A; Horwith G; Pentel PR Clin Pharmacol Ther; 2005 Nov; 78(5):456-67. PubMed ID: 16321612 [TBL] [Abstract][Full Text] [Related]
23. Effect of buspirone on withdrawal symptoms associated with smoking cessation. Hilleman DE; Mohiuddin SM; Del Core MG; Sketch MH Arch Intern Med; 1992 Feb; 152(2):350-2. PubMed ID: 1739365 [TBL] [Abstract][Full Text] [Related]
24. A randomized trial of nicotine replacement therapy in combination with reduced-nicotine cigarettes for smoking cessation. Becker KM; Rose JE; Albino AP Nicotine Tob Res; 2008 Jul; 10(7):1139-48. PubMed ID: 18629723 [TBL] [Abstract][Full Text] [Related]
25. Nicotine dependence, psychological distress and personality traits as possible predictors of smoking cessation. Results of a double-blind study with nicotine patch. Cosci F; Corlando A; Fornai E; Pistelli F; Paoletti P; Carrozzi L Addict Behav; 2009 Jan; 34(1):28-35. PubMed ID: 18804918 [TBL] [Abstract][Full Text] [Related]
26. Nicotine skin patch treatment increases abstinence, decreases withdrawal symptoms, and attenuates rewarding effects of smoking. Levin ED; Westman EC; Stein RM; Carnahan E; Sanchez M; Herman S; Behm FM; Rose JE J Clin Psychopharmacol; 1994 Feb; 14(1):41-9. PubMed ID: 8151002 [TBL] [Abstract][Full Text] [Related]
27. A randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation. Prochazka AV; Kick S; Steinbrunn C; Miyoshi T; Fryer GE Arch Intern Med; 2004 Nov; 164(20):2229-33. PubMed ID: 15534159 [TBL] [Abstract][Full Text] [Related]
28. Efficacy of the nicotine inhaler in smoking reduction: A double-blind, randomized trial. Rennard SI; Glover ED; Leischow S; Daughton DM; Glover PN; Muramoto M; Franzon M; Danielsson T; Landfeldt B; Westin A Nicotine Tob Res; 2006 Aug; 8(4):555-64. PubMed ID: 16920653 [TBL] [Abstract][Full Text] [Related]
29. Treating smokers before the quit date: can nicotine patches and denicotinized cigarettes reduce cravings? Rezaishiraz H; Hyland A; Mahoney MC; O'Connor RJ; Cummings KM Nicotine Tob Res; 2007 Nov; 9(11):1139-46. PubMed ID: 17978987 [TBL] [Abstract][Full Text] [Related]
30. Effects of atomoxetine on subjective and neurocognitive symptoms of nicotine abstinence. Ray R; Rukstalis M; Jepson C; Strasser A; Patterson F; Lynch K; Lerman C J Psychopharmacol; 2009 Mar; 23(2):168-76. PubMed ID: 18515446 [TBL] [Abstract][Full Text] [Related]
31. Treatment of adolescent smokers with the nicotine patch. Hanson K; Allen S; Jensen S; Hatsukami D Nicotine Tob Res; 2003 Aug; 5(4):515-26. PubMed ID: 12959789 [TBL] [Abstract][Full Text] [Related]
32. N-acetylcysteine for therapy-resistant tobacco use disorder: a pilot study. Prado E; Maes M; Piccoli LG; Baracat M; Barbosa DS; Franco O; Dodd S; Berk M; Vargas Nunes SO Redox Rep; 2015 Sep; 20(5):215-22. PubMed ID: 25729878 [TBL] [Abstract][Full Text] [Related]
33. Nicotine patch and paroxetine for smoking cessation. Killen JD; Fortmann SP; Schatzberg AF; Hayward C; Sussman L; Rothman M; Strausberg L; Varady A J Consult Clin Psychol; 2000 Oct; 68(5):883-9. PubMed ID: 11068974 [TBL] [Abstract][Full Text] [Related]
34. The effect of N-acetylcysteine on brain glutamate and gamma-aminobutyric acid concentrations and on smoking cessation: A randomized, double-blind, placebo-controlled trial. Schulte M; Goudriaan AE; Kaag AM; Kooi DP; van den Brink W; Wiers RW; Schmaal L J Psychopharmacol; 2017 Oct; 31(10):1377-1379. PubMed ID: 28922968 [TBL] [Abstract][Full Text] [Related]
35. The efficacy of N-acetylcysteine in the treatment of methamphetamine dependence: a double-blind controlled, crossover study. Mousavi SG; Sharbafchi MR; Salehi M; Peykanpour M; Karimian Sichani N; Maracy M Arch Iran Med; 2015 Jan; 18(1):28-33. PubMed ID: 25556383 [TBL] [Abstract][Full Text] [Related]
36. A randomized, placebo-controlled trial of N-acetylcysteine plus imaginal desensitization for nicotine-dependent pathological gamblers. Grant JE; Odlaug BL; Chamberlain SR; Potenza MN; Schreiber LR; Donahue CB; Kim SW J Clin Psychiatry; 2014 Jan; 75(1):39-45. PubMed ID: 24345329 [TBL] [Abstract][Full Text] [Related]
37. Evaluating N-acetylcysteine for early and end-of-treatment abstinence in adult cigarette smokers. McClure EA; Wahlquist AE; Tomko RL; Baker NL; Carpenter MJ; Bradley ED; Cato PA; Gipson CD; Gray KM Drug Alcohol Depend; 2021 Aug; 225():108815. PubMed ID: 34171822 [TBL] [Abstract][Full Text] [Related]
38. N-acetylcysteine for cessation of tobacco smoking: rationale and study protocol for a randomised controlled trial. Arancini L; Bortolasci CC; Dodd S; Dean OM; Berk M Trials; 2019 Sep; 20(1):555. PubMed ID: 31500670 [TBL] [Abstract][Full Text] [Related]
39. Tobacco use during cannabis cessation: Use patterns and impact on abstinence in a National Drug Abuse Treatment Clinical Trials Network study. McClure EA; Baker NL; Sonne SC; Ghitza UE; Tomko RL; Montgomery L; Babalonis S; Terry GE; Gray KM Drug Alcohol Depend; 2018 Nov; 192():59-66. PubMed ID: 30218864 [TBL] [Abstract][Full Text] [Related]
40. The Role of Twice-Daily N-acetylcysteine (NAC) 2400 mg in Smoking Cessation: A Randomized, Placebo-Controlled Trial in Indonesia. Harlivasari AD; Susanto AD; Taufik FF; Ginting TT Cureus; 2024 Feb; 16(2):e54322. PubMed ID: 38500894 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]